REC617

- Influenza Vaccine
Influenza is an infectious respiratory disease caused by the influenza virus that infects the nose, throat and sometimes lungs. The symptoms range from mild to severe and can sometimes lead to death. According to Frost Sullivan, the best way to prevent the flu is to get a flu shot every year. People over 65 years of age, children under 5 years of age and people with certain chronic diseases are at relatively high risk of serious complications if they contract influenza. According to the National Center for Disease Control and Prevention, there were about 1.1 million new influenza cases and 70 deaths in China in 2020.
REC617
- Recbio is developing novel adjuvants to enhance tolerance, immunogenicity protection time and cross-protection ability
- REC617 is being developed using a similar approach to Sanofi's Flublok with a novel, self-developed adjuvant to further improve its tolerance, immunogenicity, protection durability, cross-protection capability and manufacturing scalability